EC Number | Application | Comment | Organism |
---|---|---|---|
2.7.4.14 | medicine | screening of acyclic phosphonate analogs to find antimetabolites for antivirus and anticancer therapies | Homo sapiens |
EC Number | Cloned (Comment) | Organism |
---|---|---|
2.7.4.14 | overexpression in Escherichia coli, wild type and selenomethionine labelled protein | Homo sapiens |
EC Number | Crystallization (Comment) | Organism |
---|---|---|
2.7.4.14 | of the selenomethionine labelled protein in complex with UMP, CMP, ADP, AMP-PCP, cidofovor and P1-(5-adenosyl) P5-(5-uridyl) pentaphosphate | Homo sapiens |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
2.7.4.14 | 5-Br-uracil vinylphosphonate | - |
Homo sapiens | |
2.7.4.14 | 5-Cl-uracil vinylphosphonate | - |
Homo sapiens | |
2.7.4.14 | 5-F-Phe-uracil vinylphosphonate | - |
Homo sapiens | |
2.7.4.14 | 5-Phe-S-uracil vinylphosphonate | - |
Homo sapiens | |
2.7.4.14 | 5-Phe-uracil vinylphosphonate | - |
Homo sapiens | |
2.7.4.14 | uracil vinylphosphonate | - |
Homo sapiens |
EC Number | KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
2.7.4.14 | 0.07 | - |
CMP | - |
Homo sapiens | |
2.7.4.14 | 0.13 | - |
UMP | - |
Homo sapiens | |
2.7.4.14 | 1 | - |
Cidofovir | - |
Homo sapiens | |
2.7.4.14 | 1.1 | - |
dCMP | - |
Homo sapiens | |
2.7.4.14 | 1.3 | - |
dUMP | - |
Homo sapiens |
EC Number | Metals/Ions | Comment | Organism | Structure |
---|---|---|---|---|
2.7.4.14 | Mg2+ | - |
Homo sapiens |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.7.4.14 | Homo sapiens | P30085 | - |
- |
EC Number | Purification (Comment) | Organism |
---|---|---|
2.7.4.14 | of the recombinant protein | Homo sapiens |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.7.4.14 | ATP + (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine | Cidofovir | Homo sapiens | ADP + (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine | - |
? | |
2.7.4.14 | ATP + CMP | - |
Homo sapiens | ADP + CDP | - |
? | |
2.7.4.14 | ATP + dCMP | - |
Homo sapiens | ADP + dCDP | - |
? | |
2.7.4.14 | ATP + dUMP | no activity with CDP, dTMP, AMP, GMP | Homo sapiens | ADP + dUDP | - |
? | |
2.7.4.14 | ATP + UMP | - |
Homo sapiens | ADP + UDP | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.7.4.14 | cytidylate kinase | - |
Homo sapiens |
2.7.4.14 | UCK | - |
Homo sapiens |
2.7.4.14 | UMP-CMP kinase | - |
Homo sapiens |
EC Number | Ki Value [mM] | Ki Value maximum [mM] | Inhibitor | Comment | Organism | Structure |
---|---|---|---|---|---|---|
2.7.4.14 | 0.016 | - |
5-Cl-uracil vinylphosphonate | - |
Homo sapiens | |
2.7.4.14 | 0.017 | - |
5-Br-uracil vinylphosphonate | - |
Homo sapiens | |
2.7.4.14 | 0.028 | - |
5-Phe-S-uracil vinylphosphonate | - |
Homo sapiens | |
2.7.4.14 | 0.7 | - |
uracil vinylphosphonate | - |
Homo sapiens |
EC Number | IC50 Value | IC50 Value Maximum | Comment | Organism | Inhibitor | Structure |
---|---|---|---|---|---|---|
2.7.4.14 | 0.03 | - |
- |
Homo sapiens | 5-Cl-uracil vinylphosphonate | |
2.7.4.14 | 0.035 | - |
- |
Homo sapiens | 5-Br-uracil vinylphosphonate | |
2.7.4.14 | 0.05 | - |
- |
Homo sapiens | 5-Phe-S-uracil vinylphosphonate | |
2.7.4.14 | 0.12 | - |
amplitude 50% | Homo sapiens | 5-Phe-S-uracil vinylphosphonate | |
2.7.4.14 | 0.23 | - |
- |
Homo sapiens | 5-F-Phe-uracil vinylphosphonate | |
2.7.4.14 | 1.2 | - |
- |
Homo sapiens | uracil vinylphosphonate |